AHRQ.GOV : www.ahrq.gov - 29 in TOP 100 MEDICAL SITES. Rating: 174000.

Description: Research agenda, grant announcements, contract solicitations, policies and procedures, special initiatives, call for partners, small business innovation research, and research dissertations, training, and career development.

Most popular searches: www.arq.gov, small business innovative research program, www.ahrq.com, contracts, wwwahrq.gov, www.ahrq.gvo, initiatives, sbir, ww.ahrq.gov, www.ahrq.ogv, program announcements, grant announcements, agency for healthcare research and quality, www.ahq.gov, www.ahrq.gv, www.ahrq.ov, www.ahqr.gov, ahrq, agency for health care policy and research, requests for proposals, applications, www.ahrq.go, www.hrq.gov, training, small conference grants, wwwa.hrq.gov, , www.arhq.gov, grantmakers, ww.ahrq.gov, policies, wwwahrq.gov, ww.wahrq.gov, grants, funding, federal aid, awards, www.ahrqg.ov, www.ahr.gov, rfa, rfp, health services, programs, partners, ahcpr, www.harq.gov, www.ahr.qgov, www.ahrqgov, www.ahrq.gov, www.ahrq.gov

Neuralstem wins stem cell transplant patent
Neuralstem Inc., which is developing ways to produce stem cells of the brain and spinal cord, has won a patent on how to produce them and transplant them into patients.
feeds.bizjournals.com

Insurance Executive Pay Curbed in Bill
Senate Democrats, responding to charges that expanding health coverage would enrich insurance companies, voted to limit insurance executives' compensation.
online.barrons.com

Martek Biosciences: Can It Turn Algae into Gold, Or at the Least Oil?
Jamie Moye submits:Martek Biosciences Corp. (MATK) is a global leader in the production of docosahexaenoic acid from microalgae and arachidonic acid from fungus, and as such stands to benefit from the combined U.S. demographics of an expected uptick in U.S. births, aging baby boomers and an apparently health-conscious Generation Y. “Wait a minute! Docosahex-what? Arachid-what? Made from microalgae? Fungus? And, what does this have to do with babies, teenagers and the soon-to-be elderly?” Complete Story »
seekingalpha.com

Array BioPharma Announces Positive Interim Results for Phase 1 Study of Its HER2 Inhibitor, ARRY-380, in Cancer Patients (Business Wire)
BOULDER, Colo.----Array BioPharma Inc. today announced positive interim results of its novel, small molecule HER2 inhibitor, ARRY-380, in a Phase 1 trial in advanced cancer patients.
us.rd.yahoo.com

Quest Diagnostics Net Rises
Quest Diagnostics said earnings jumped 6.9% as the medical-testing provider's margins rose and it saw increased demand for some of its clinical tests. The company also increased its share-buyback program.
online.wsj.com